Gross Profit - Ascendis Pharma A/S (NASDAQ:ASND) - Alpha Spread

Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 154 USD 3.44%
Market Cap: 8.8B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ascendis Pharma A/S
Gross Profit Peer Comparison

Comparables:
GMAB
GLTO
B
BAVA
BIOPOR
SANION

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
Gross Profit
€271.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genmab A/S
NASDAQ:GMAB
Gross Profit
kr18.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Galecto Inc
NASDAQ:GLTO
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Gross Profit
kr3.5B
CAGR 3-Years
91%
CAGR 5-Years
62%
CAGR 10-Years
19%
Bioporto A/S
CSE:BIOPOR
Gross Profit
kr24.1m
CAGR 3-Years
19%
CAGR 5-Years
6%
CAGR 10-Years
8%
Saniona AB
STO:SANION
Gross Profit
-kr22.9m
CAGR 3-Years
53%
CAGR 5-Years
9%
CAGR 10-Years
N/A

See Also

What is Ascendis Pharma A/S's Gross Profit?
Gross Profit
271.7m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Gross Profit amounts to 271.7m EUR.

What is Ascendis Pharma A/S's Gross Profit growth rate?
Gross Profit CAGR 1Y
187%

Over the last year, the Gross Profit growth was 187%.

Back to Top